Social media

Operationalizing new outcome measures in obesity trials is challenging. From selecting the right COAs and DHTs to ensuring clean, high-quality data, every choice impacts trial outcomes. Our upcoming live webinar will pr...

Operationalizing new outcome measures in obesity trials is challenging. From selecting the right COAs and DHTs to ensuring clean, high-quality data, every choice impacts trial outcomes. Our upcoming live webinar will pr...

Biomarkers aren’t just supporting drug development, they’re driving it. This expert-led report produced in conjunction with Drug Target Review explores how biomarker science is advancing trial design, accelerating clinic...

Biomarkers aren’t just supporting drug development, they’re driving it. This expert-led report produced in conjunction with Drug Target Review explores how biomarker science is advancing trial design, accelerating clinic...

ICON recognises #WorldCancerResearchDay to raise awareness of cancer which causes 1 in 6 deaths globally. In the past 5 years, we have participated in 844 oncology and haematologic malignancy Phase 1-4 clinical studies, ...

In recognition of World Cancer Research Day, ICON’s Patient-Centred Outcomes (PCO) team proudly highlights its ongoing commitment to advancing oncology research. With a dedicated team of over 45 experts across Europe a...

We’re delighted to announce that Deepali Suri has joined as President of ICON Biotech. With a proven track record in clinical development, operational excellence, and digital innovation, Deepali will lead our support for...

ICON has recently carried out a comparison of the four most commonly used formulae to adjust the QT-interval for heart rate in healthy subjects. We analysed ECG data from over 22,000 healthy volunteers in phase 1 tria...

At tomorrow's OCT Southern California, Madelaine MacKay, ICON’s Senior Director, Product Delivery, will take part in an insightful AI panel discussion. As AI continues to reshape the clinical research industry, this pane...

ICON’s Regulatory Affairs team is proud to sponsor #RAPSConvergence 2025, the leading event for regulatory professionals kicking off October 7th in Pittsburgh, PA. Visit us at booth 409 and meet the team. Venkat Sunkar...

ICON’s Regulatory Affairs team is proud to sponsor #RAPSConvergence 2025, the leading event for regulatory professionals kicking off October 7th in Pittsburgh, PA. Visit us at booth 409 and meet the team. Venkat Sunkar...

We are delighted to share the winning entries from the 2025 ICON Cares environmental photo contest. This year’s theme, Nature’s Palette, invited employees to capture the vibrant colours and striking beauty of the natura...